Accelerated Approval Is Not Conditional Approval Insights From International Expedited Approval Programs

This Viewpoint compares the US Food and Drug Administration's accelerated approval pathway for drugs and biologics with similar programs developed by other international regulatory health authorities.

Automated summary

This viewpoint compares the US FDA's accelerated approval pathway for drugs and biologics with similar programs developed by other international regulatory health authorities.